Camp4 Therapeutics Corporation · NASDAQ:CAMP

Andrew J. Schwab reported a 9.90% stake in Camp4 Therapeutics Corporation (Schedule 13D/A)

Event Aug 27, 2026 · Filed Aug 31, 2026

Andrew J. Schwab reported a 9.90% stake in Camp4 Therapeutics Corporation, 6,379,125 shares, with active intent on Aug 27, 2026. Filed Aug 31, 2026 (Schedule 13D/A).

Stake
9.90%
Shares
6,379,125
Intent
Active
What changed
Stake changed
Filed together
8 holders

The filing in full

HolderStakeShares
5AM Ventures VI, L.P.3.20%2,033,270
5AM Partners VI, LLC3.20%2,033,270
5AM Ventures VII, L.P.6.30%4,034,085
5AM Partners VII, LLC6.30%4,034,085
5AM Opportunities II, L.P.0.50%302,770
5AM Opportunities II (GP), LLC0.50%302,770
Andrew J. Schwab9.90%6,379,125
Kush Parmar9.90%6,370,125

Source

View original at SEC

Related